Initiation of Clozapine Therapy in a Patient with Preexisting Leukopenia: A Discussion of the Rationale of Current Treatment Options

Authors: Boshes R.A.1; Manschreck T.C.1; Desrosiers J.2; Candela S.3; Hanrahan-Boshes M.4

Source: Annals of Clinical Psychiatry, Volume 13, Number 4, December 2001 , pp. 233-237(5)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Clozapine remains the most effective agent for diminishing or eliminating psychotic symptoms in treatment-resistant patients. However, among such patients, a small percentage (<3.0%) develops clozapine-induced granulocytopenia (CIG). In spite of the fact that lithium and granulocyte colony stimulating factor (G-CSF) have been shown to reverse CIG, many such patients are consigned to treatment with antipsychotic agents that have failed in the past. Apparently, their physicians are not aware that these patients can be salvaged for ongoing clozapine treatment. We report the effectiveness of lithium in reversing CIG in a young man with preexisting mild granulocytopenia. The rapidity of onset of leukocyte depletion is discussed in light of previously hypothesized autoimmune mechanisms of CIG. This case dramatizes the importance of lithium (or G-CSF) augmentation in those patients to maintain clozapine treatment so that their neutropenia can be reversed, and they can continue to benefit from the unique antipsychotic qualities of clozapine.

Keywords: clozapine-induced granulocytopenia; leukopenia; neutropenia; lithium; autoimmune disorder

Language: English

Document Type: Regular paper

Affiliations: 1: Department of Psychiatry, VAMC Brockton/West Roxbury, Dr. John C. Corrigan Mental Health Center, Harvard Medical School, Massachusetts 2: Dr. John C. Corrigan Mental Health Center, Harvard Medical School, Massachusetts 3: Department of Psychology, Dr. John C. Corrigan Mental Health Center, Harvard University, Massachusetts 4: Laboratory of Clinical and Experimental Psychopathology, Department of Psychiatry, Dr. John C. Corrigan Mental Health Center, Harvard Medical School, Massachusetts

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A